“Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis”, Baghdad Sci.J, vol. 19, no. 6, p. 1191, Dec. 2022, doi: 10.21123/bsj.2022.6431.